Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Vodafone Group

Start price
Target price
Perf. (%)
€0.81
27.04.24
-
27.04.25
-
27.04.24

buy
Heidelberger Druckmaschinen AG

Start price
Target price
Perf. (%)
€0.95
27.04.24
-
27.04.25
-
27.04.24

buy
Varta AG

Start price
Target price
Perf. (%)
€9.43
13.04.24
-
13.04.25
-0.32%
27.04.24

buy
Epigenomics AG

Start price
Target price
Perf. (%)
€1.57
13.04.24
-
13.04.25
-2.23%
27.04.24

buy
Tilray Inc

Start price
Target price
Perf. (%)
€1.70
13.04.24
-
13.04.25
-1.21%
27.04.24

buy
Fanuc Corp.

Start price
Target price
Perf. (%)
€26.67
13.04.24
-
13.04.25
1.99%
27.04.24

buy
Heidelberger Druckmaschinen AG

Start price
Target price
Perf. (%)
€1.01
13.04.24
-
13.04.25
-10.57%
27.04.24

Helma Eigenheimbau AG

Start price
Target price
Perf. (%)
€1.06
18.04.24
-
18.04.25
-26.07%
27.04.24

Bit Mining Ltd. ADR

Start price
Target price
Perf. (%)
€3.22
23.04.24
-
23.04.25
-23.60%
27.04.24

buy
Biodexa Pharmaceuticals Plc

Start price
Target price
Perf. (%)
€1.43
26.04.24
-
26.04.25
-12.59%
27.04.24

Annovis Bio Inc.

Start price
Target price
Perf. (%)
€14.14
26.04.24
-
26.04.25
14.57%
27.04.24

Risky Investment
buy
Vonovia SE

Start price
Target price
Perf. (%)
€28.88
29.12.23
€30.00
29.12.24
-10.46%
27.04.24

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€262.20
03.07.23
€270.00
03.07.24
-25.88%
27.04.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Advanced Micro Devices Inc.

Start price
Target price
Perf. (%)
€163.46
04.04.24
€165.00
04.04.25
-9.04%
27.04.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Future proof or reliable business model
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.91
08.04.24
€3.00
08.04.25
-21.66%
27.04.24

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
adidas AG

Start price
Target price
Perf. (%)
€221.00
17.04.24
€221.00
17.04.25
4.71%
27.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€1.31
16.04.24
-
16.04.25
6.59%
27.04.24

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-1.53%
27.04.24

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.85
25.04.24
-
25.04.25
-1.11%
27.04.24

buy
Actinium Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.14
25.04.24
-
25.04.25
5.13%
27.04.24

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.73
25.04.24
-
25.04.25
0.80%
27.04.24

Risky Investment
buy
X4 Pharmaceuticals, Inc.

Start price
Target price
Perf. (%)
€1.08
25.04.24
-
25.04.25
5.93%
27.04.24

buy
Tesla Inc

Start price
Target price
Perf. (%)
€217.05
23.08.23
€270.00
23.08.24
-24.74%
27.04.24

buy
Palantir Technologies Inc.

Start price
Target price
Perf. (%)
€23.20
26.03.24
-
26.04.24
-8.73%
27.04.24

buy
Innocan Pharma Corp.

Start price
Target price
Perf. (%)
€0.21
26.03.24
€2.00
26.04.24
-6.43%
27.04.24